FDA Patient Network’s Inaugural Meeting Seeks Input In Regulatory Decision-Making

In the shadow of final negotiations over PDUFA reauthorization, the agency is inviting patients, their representatives, industry and academics to discuss how best to use patient input in decisions on regulated drugs, devices and biologics.